Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum

Brain Research

Volumn 1046, Issue 1-2, 2005, Pages 90-96

  Nam, Eunjoo ^a   Seung, Min Lee ^a   Seong, Eun Koh ^b   Wan, Seok Joo ^c   Maeng, Sungho ^a   Heh, In Im ^a   Yong, Sik Kim ^a  

^a Seoul National University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Korea Food and Drug Administration   (South Korea)

Author keywords

3 Nitropropionic acid (3 NP); Antioxidant; Melatonin; Neuronal damage; Oxidative stress

Indexed keywords

3 NITROPROPIONIC ACID; CARBONYL DERIVATIVE; DOPAMINE; MALONALDEHYDE; MELATONIN; TRIPHENYLTETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NERVE INJURY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STEREOTAXIS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; CELL DEATH; CORPUS STRIATUM; LIPID PEROXIDATION; MALE; MELATONIN; MOTOR SKILLS; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; ROTAROD PERFORMANCE TEST;

EID: 20144376099     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.03.053     Document Type: Article

References (38)

1. M.F. Beal, N.W. Kowall, K.J. Swartz, R.J. Ferrante, and J.B. Martin Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions Synapse 3 1989 38 47
2. M.F. Beal, W.R. Matson, K.J. Swartz, P.H. Gamache, and E.D. Bird Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid J. Neurochem. 55 1990 1327 1339
3. M.F. Beal, E. Brouillet, B.G. Jenkins, R.J. Ferrante, N.W. Kowall, J.M. Miller, E. Storey, R. Srivastava, B.R. Rosen, and B.T. Hyman Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J. Neurosci. 13 1993 4181 4192
4. W.R. Bidlack, and A.L. Tappel Fluorescent products of phospholipids during lipid peroxidation Lipids 8 1973 203 207
5. Z. Binienda, C. Simmons, S. Hussain, W. Slikker Jr., and S.F. Ali Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain Neurosci. Lett. 251 1998 173 176
6. A. Bjorklund, K. Campbell, D.J.S. Sirinathsinghji, R.A. Fricker, and S.B. Dunnett Functional capacity of striatal transplants in the rat Huntington model S.B. Dunnett A. Bjorklund Functional Neural Transplantation 1994 Raven Press New York 157 195
7. S.C. Bondy, and D.K. Lee Oxidative stress induced by glutamate receptor agonists Brain Res. 610 1993 229 233
8. E. Brouillet, B.G. Jenkins, B.T. Hyman, R.J. Ferrante, N.W. Kowall, R. Srivastava, D.S. Roy, B.R. Rosen, and M.F. Beal Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid J. Neurochem. 60 1993 356 359
9. J. Cabrera, R.J. Reiter, D. Tan, W. Qi, R.M. Sainz, J.C. Mayo, J.J. Garcia, S.J. Kim, and G. El-Sokkary Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings Neuropharmacology 39 2000 507 514
10. J.L. Cadet, M. Katz, V. Jackson-Lewuis, and S. Fahn Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence Brain Res. 476 1989 10 15
11. L.S. Carman, F.H. Gage, and C.W. Shults Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior Brain Res. 553 1991 275 283
12. C.J. Coles, D.E. Edmondson, and T.P. Singer Inactivation of succinate dehydrogenase by 3-nitropropionate J. Biol. Chem. 254 1979 5161 5167
13. B. Costall, R.J. Naylor, and J.E. Olley The substantia nigra and stereotyped behaviour Eur. J. Pharmacol. 18 1972 95 106
14. J.A. Dykens Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca and Na: implications for neurodegeneration J. Neurochem. 63 1994 584 591
15. J.Y. Joo, and H. Manev Opposite effects of pinealectomy and melatonin administration on brain damage following cerebral focal ischemia in rat Restor. Neurol. Neurosci. 13 1998 185 191
16. H. Khaldy, G. Escames, J. Leon, L. Bikjdaouene, and D. Acuna-Castroviejo Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion Neurobiol. Aging 24 2003 491 500
17. P. Klivenyi, O.A. Andreassen, R.J. Ferrante, A. Dedeoglu, G. Mueller, E. Lancelot, M. Bogdanov, J.K. Andersen, D. Jiang, and M.F. Beal Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine J. Neurosci. 20 2000 1 7
18. T.K. Koutouzis, C.V. Borlongan, T.B. Freeman, D.W. Cahill, and P.R. Sanberg Intrastriatal 3-nitropropionic acid: a behavioural assessment NeuroReport 5 1994 2241 2245
19. T.K. Koutouzis, C.V. Borlongan, T. Scorcia, I. Creese, D.W. Cahill, T.B. Freeman, and P.R. Sanberg Systemic 3-nitropropionic acid: long-term effects on locomotor behavior Brain Res. 646 1994 242 246
20. M. La Fontaine, J. Geddes, A. Banks, and D.A. Butterfield Effect of exogenous and endogenous antioxidants on 3-nitropropionic acid-induced oxidative stress and striatal lesions: insights into Huntington's disease J. Neurochem. 75 2000 1709 1715
21. I.P. Lapin, S.M. Mirzaev, I.V. Ryzov, and G.F. Oxenkrug Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice J. Pineal Res. 24 1998 215 218
22. I. Lastres-Becker, F. Fezza, M. Cebeira, T. Bisogno, J.A. Ramos, A. Milone, J. Fernandez-Ruiz, and V. Di Marzo Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease NeuroReport 12 2001 2125 2129
23. I. Lastres-Becker, H.H. Hansen, F. Berrendero, R. De Miguel, A. Perez-Rosado, J. Manzanares, J.A. Ramos, and J. Fernandez-Ruiz Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease Synapse 44 2002 23 35
24. R.L. Levine, D. Garland, C.N. Oliver, A. Amici, I. Climent, A.G. Lenz, B.W. Ahn, S. Shaltiel, and E.R. Stadtman Determination of carbonyl content in oxidatively modified proteins Methods Enzymol. 186 1990 464 478
25. A.C. Ludolph, F. He, P.S. Spencer, J. Hammerstad, and M. Sabri 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin Can. J. Neurol. Sci. 18 1991 492 498
26. M. Martin, M. Macias, G. Escames, J. Leon, and D. Acuna-Castroviejo Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress FASEB J. 14 2000 1677 1679
27. R.T. Matthews, L. Yang, B.G. Jenkins, R.J. Ferrante, B.R. Rosen, R. Kaddurah-Daouk, and M.F. Beal Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease J. Neurosci. 18 2000 156 163
28. A. Mendlin, F.J. Martin, and B.L. Jacobs Involvement of dopamine D2 receptors in apomorphine-induced facilitation of forebrain serotonin output Eur. J. Pharmacol. 351 1998 291 298
29. N. Nakao, and P. Brundin Effects of a-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of ouinolate or 3-nitropropionic acid Neuroscience 76 1997 749 761
30. R.J. Reiter Aging and oxygen toxicity: relation to changes in melatonin Ann. N. Y. Acad. Sci. 20 1997 201 213
31. R.J. Reiter, D. Acuna-Castroviejo, D.X. Tan, and S. Burkhardt Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system Ann. N. Y. Acad. Sci. 939 2001 200 215
32. S.D. Skaper, M. Floreani, M. Ceccon, L. Facci, and P. Giusti Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin Ann. N. Y. Acad. Sci. 890 1999 107 118
33. D.X. Tan, L.C. Manchester, R.J. Reiter, W. Qi, S.J. Kim, and G.H. El-Sokkary Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice J. Neurosci. Res. 54 1998 382 389
34. C.E. Teunissen, M. Markerink-van Ittersum, C. de Bruijn, H.W. Steinbusch, and J. de Vente Evaluation of 3-nitrotyrosine as a marker for 3-nitropropionic acid-induced oxidative stress in Lewis and Wistar rats and strain-specific whole brain spheroid cultures Brain Res. 931 2002 5 20
35. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res. 24 1970 485 493
36. N.S. Wexler, E.A. Rose, and D.E. Housman Molecular approaches to hereditary diseases of the nervous system: Huntington's disease as a paradigm Annu. Rev. Neurosci. 14 1991 503 529
37. U. Wüllner, A.B. Young, J.B. Penny, and M.F. Beal 3-Nitropropionic acid toxicity in the striatum J. Neurochem. 63 1994 1772 1781
38. G.D. Zeevalk, E. Derr-Yellin, and W.J. Nicklas NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid J. Neurochem. 64 1995 455 458